• Home
  • Blog
  • Issues
    • History of the FDA
    • Approval
    • Drug Development
    • Safety
    • Theory of Harm
    • FDA Incentives
    • Where Is the Market Failure Argument?
    • Medical Devices
    • Reform Options
    • Voluntary Provisions
    • Managing Risky Products
  • Publications
  • Features
    • Glossary
    • Links
    • Quotations
    • References
  • About
  • Donate
Search
  • Home
  • Blog
  • Issues
    • History of the FDA
    • Approval
    • Drug Development
    • Safety
    • Theory of Harm
    • FDA Incentives
    • Where Is the Market Failure Argument?
    • Medical Devices
    • Reform Options
    • Voluntary Provisions
    • Managing Risky Products
  • Publications
  • Features
    • Glossary
    • Links
    • Quotations
    • References
  • About
  • Donate
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
FDAReview.org
  • Home
  • Blog
  • Issues
    • History of the FDA
    • Approval
    • Drug Development
    • Safety
    • Theory of Harm
    • FDA Incentives
    • Where Is the Market Failure Argument?
    • Medical Devices
    • Reform Options
    • Voluntary Provisions
    • Managing Risky Products
  • Publications
  • Features
    • Glossary
    • Links
    • Quotations
    • References
  • About
  • Donate

Monthly Archives: March 2020

Trust Private Enterprise to Flatten the Curve

Raymond March - March 27, 2020 0

FDA Should Expand Options for Coronavirus Patients

Ross Marchand - March 26, 2020 0

The Mask Madness of Big Government

K. Lloyd Billingsley - March 26, 2020 0

To Battle Covid-19, Cut Regulation!

Raymond March - March 25, 2020 0

Favor Local Action to Combat the Coronavirus

Raymond March - March 19, 2020 0

FDA Acknowledges Coronavirus Is Causing More Drug Shortages

Raymond March - March 6, 2020 0

FDA’s Approval of Generic Daraprim Offers Lessons on Drugs Prices

Raymond March - March 5, 2020 0
  • Home
  • Blog
  • Issues
    • History of the FDA
    • Approval
    • Drug Development
    • Safety
    • Theory of Harm
    • FDA Incentives
    • Where Is the Market Failure Argument?
    • Medical Devices
    • Reform Options
    • Voluntary Provisions
    • Managing Risky Products
  • Publications
  • Features
    • Glossary
    • Links
    • Quotations
    • References
  • About
  • Donate
© 2023 Independent Institute, 100 Swan Way, Oakland CA 94621-1428 | (510) 632‑1366.